Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GEFITINIB vs GEODON: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GEFITINIB vs GEODON: Safety Overview

Metric GEFITINIB GEODON
Total FAERS Reports 4,697 133
Deaths Reported 1,047 6
Death Rate 22.3% 4.5%
Hospitalizations 853 16
Average Patient Age 66.4 yrs 40.4 yrs
% Female Patients 66.4% N/A
FDA Approval Date Apr 26, 2023 N/A
Manufacturer Teva Pharmaceuticals, Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A